Behavioral Core
行为核心
基本信息
- 批准号:10626089
- 负责人:
- 金额:$ 43.81万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2021
- 资助国家:美国
- 起止时间:2021-08-15 至 2026-05-31
- 项目状态:未结题
- 来源:
- 关键词:AddressAmalgamAnimal ModelAnimalsArizonaAttentionBehaviorBehavior DisordersBehavior assessmentBehavioralBehavioral AssayBiogenic AminesBioinformaticsBiological AssayBrainChronicClassificationCognitionCognition DisordersCognitiveCognitive deficitsCollectionCommunitiesComplexCouplingDSM-VDataDatabase Management SystemsDecision MakingDetectionDiagnosisDrug abuseDrug usageElectronicsEmotionalEvaluationExposure toFunctional disorderGenderGeneticGroomingHumanImpaired cognitionImpairmentIntakeIntellectual impairmentInternationalInterventionLearningLipidsMachine LearningMaintenanceMarbleMeasurementMeasuresMediatingMemoryMethodologyMicrodialysisMissionModelingMolecularMolecular TargetMorbidity - disease rateNational Institute of Drug AbuseNeural PathwaysNeuromodulatorNeuropharmacologyNeurotransmittersOpiate AddictionOpioidPainPain MeasurementPain ResearchPathologyPatientsPeer ReviewPeptidesPerceptionPerformancePersistent painPharmaceutical PreparationsPharmacologyPre-Clinical ModelProcessPublicationsRecording of previous eventsRelapseReproducibilityResearchResearch PersonnelResearch ProposalsRewardsSelf AdministrationSignal TransductionSocial InteractionSpeedStandardizationSubstance Use DisorderSymptomsSystemTestingTimeUnited States National Institutes of HealthUniversitiesaddictionbehavior measurementbehavior testbehavioral outcomechronic painchronic pain patientclinical diagnosticsclinical translationclinically relevantcognitive functionconditioned place preferencedesigndiagnostic criteriadriving behavioreffective therapyemotional traumaexecutive functionexperimental studygenetic approachgenetic manipulationin vivoinsightlarge datasetslearning strategymortalityneglectneural circuitneural networkneurochemistrynovelobject recognitionopioid epidemicopioid exposureopioid misuseopioid useopioid use disorderpre-clinicalpsychologicsocialsubstance misusesynergismtranslational applicationstranslational potentialwelfare
项目摘要
Project Summary - Behavioral Core
Physical and/or emotional trauma are at the crux of the ongoing pain and opioid epidemics. The complex neural
circuitry implicated in pain and opioid misuse challenges our understanding of the underlying pathologies and
potential treatments. Cognition and decision-making are certainly impaired in patients with pain. However, the
opioids compounds used to treat patients with chronic pain, are themselves also associated with cognitive
impairment. Despite the recognition of opioid use disorder (OUD) as a cognitive disorder, the complex
neurochemical signaling driving this behavior in cognitive models of OUD remains unclear. We propose a
Behavioral Core to synergize the neuro-analytical measurements in Core 3 with the genetically-edited animals
in Core 2. This alliance will provide new meaningful insights into the mechanisms of opioid reward and addiction
and simultaneously verify new molecular targets and neural pathways underlying OUDs.
The Behavioral Core will utilize the DSM-V definition of opioid used disorder (OUD) (i.e., ten major
behaviors ranging from inter- and intrapersonal dysfunction to physical and psychological difficulties resulting
from increased intake of opioids on a 0-10 scoring system) and apply these to animal behavioral tests to create
a similar scoring system for preclinical addiction studies for reliable clinical translational application. These
behaviors will be performed in coordination with Cores-2 and Core-3, to provide large data sets optimal for an
OUD analysis with bioinformatic and machine learning strategies. In addition, novel molecular targets, therapies
and neural networks will be studied to determine to what extent new interventions significantly reduce OUD, in
line with the NIH/NIDA mission. The Behavioral Core offer the following pre-established assays:
SA1- Establish preclinical models of addictive states that are representative of DSM-V criteria for OUDs.
SA2- Establish preclinical models of cognition for evaluation of consequences of opioid exposure.
SA3- Integrate OUD behavioral assessment with dynamic neurochemical collection.
The escalating number of fatalities from the opioid epidemic necessitates both better interventions to
treat OUD and a better understanding of the neural circuits underlying opioid use and addiction. To address this
problem, our studies use preclinical animal models based on criteria from human OUD patients. Studies in the
Behavioral Core specifically target the circuitry underlying cognitive dysfunction in addictive states that promote
poor decision making, drug taking, maintenance and relapse. Our proposed experiments implement multiple
technical approaches that will allow for understanding of circuits mediating cognitive aspects of the addictive
state. The data generated from the Cores will ultimately lead to hypothesis driven NIH/NIDA research proposals,
peer-reviewed publications, national and international presentations and an electronic database system for the
scientific community that will speed the discovery of effective therapies for OUD.
项目摘要 - 行为核心
身体和/或情感创伤是持续疼痛和阿片类药物流行的症结所在。复杂的神经
与疼痛和阿片类药物滥用有关的电路挑战了我们对潜在病理学的理解
潜在的治疗方法。疼痛患者的认知和决策肯定会受到损害。然而,
用于治疗慢性疼痛患者的阿片类化合物本身也与认知能力有关
损害。尽管阿片类药物使用障碍 (OUD) 被认为是一种认知障碍,但复杂的
OUD 认知模型中驱动这种行为的神经化学信号传导仍不清楚。我们提出一个
行为核心将核心 3 中的神经分析测量与基因编辑动物相协同
核心 2。该联盟将为阿片类药物奖励和成瘾机制提供新的有意义的见解
并同时验证 OUD 背后的新分子靶点和神经通路。
行为核心将利用 DSM-V 对阿片类药物使用障碍 (OUD) 的定义(即十个主要
行为范围从人际关系和内部功能障碍到由此导致的身体和心理困难
(根据 0-10 评分系统增加阿片类药物的摄入量)并将其应用于动物行为测试以创建
用于临床前成瘾研究的类似评分系统,以实现可靠的临床转化应用。这些
行为将与 Cores-2 和 Core-3 协调执行,以提供最适合
使用生物信息学和机器学习策略进行 OUD 分析。此外,新的分子靶点、疗法
将研究神经网络以确定新干预措施在多大程度上显着减少 OUD,
符合 NIH/NIDA 的使命。行为核心提供以下预先建立的检测:
SA1-建立代表 DSM-V OUD 标准的成瘾状态临床前模型。
SA2-建立临床前认知模型以评估阿片类药物暴露的后果。
SA3-将 OUD 行为评估与动态神经化学物质收集相结合。
阿片类药物流行造成的死亡人数不断增加,需要采取更好的干预措施
治疗 OUD 并更好地了解阿片类药物使用和成瘾背后的神经回路。为了解决这个问题
为了解决这个问题,我们的研究使用基于人类 OUD 患者标准的临床前动物模型。研究于
行为核心专门针对成瘾状态下认知功能障碍的回路,从而促进
决策失误、吸毒、维持和复发。我们提出的实验实施了多个
技术方法将允许理解介导成瘾认知方面的回路
状态。核心生成的数据最终将导致假设驱动的 NIH/NIDA 研究提案,
同行评审出版物、国家和国际演示文稿以及电子数据库系统
科学界将加速发现 OUD 的有效疗法。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Tally Marie Milnes其他文献
Tally Marie Milnes的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Tally Marie Milnes', 18)}}的其他基金
Targeting the Endocannabinoid System for Headache Intervention
针对内源性大麻素系统进行头痛干预
- 批准号:
10584948 - 财政年份:2023
- 资助金额:
$ 43.81万 - 项目类别:
Endocannabinoid Targeting for Opioid Induced Respiratory Depression
内源性大麻素靶向治疗阿片类药物引起的呼吸抑制
- 批准号:
10508272 - 财政年份:2022
- 资助金额:
$ 43.81万 - 项目类别:
Blood Brain Barrier and Migraine: Effect on Therapy
血脑屏障和偏头痛:对治疗的影响
- 批准号:
10199058 - 财政年份:2017
- 资助金额:
$ 43.81万 - 项目类别:
Blood Brain Barrier and Migraine: Effect on Therapy (Diversity Supplement)
血脑屏障和偏头痛:对治疗的影响(多样性补充)
- 批准号:
10404773 - 财政年份:2017
- 资助金额:
$ 43.81万 - 项目类别:
Primary Afferent Transmission in the Trigeminal Dorsal Horn
三叉神经背角的初级传入传输
- 批准号:
8576394 - 财政年份:2011
- 资助金额:
$ 43.81万 - 项目类别:
Primary Afferent Transmission in the Trigeminal Dorsal Horn
三叉神经背角的初级传入传输
- 批准号:
8253418 - 财政年份:2011
- 资助金额:
$ 43.81万 - 项目类别:
Primary Afferent Transmission in the Trigeminal Dorsal Horn
三叉神经背角的初级传入传输
- 批准号:
8339593 - 财政年份:2011
- 资助金额:
$ 43.81万 - 项目类别:
相似国自然基金
基于Amalgam空间的Hardy空间实变理论及其应用
- 批准号:11726621
- 批准年份:2017
- 资助金额:20.0 万元
- 项目类别:数学天元基金项目
基于Amalgam空间的Hardy空间实变理论及其应用
- 批准号:11726622
- 批准年份:2017
- 资助金额:10.0 万元
- 项目类别:数学天元基金项目
金属在汞中的扩散系数
- 批准号:28870208
- 批准年份:1988
- 资助金额:2.5 万元
- 项目类别:面上项目
相似海外基金
Light-propelled dental adhesives with enhanced bonding capability
具有增强粘合能力的光驱动牙科粘合剂
- 批准号:
10741660 - 财政年份:2023
- 资助金额:
$ 43.81万 - 项目类别:
Conduits: Mount Sinai Health System Translational Science Hub
管道:西奈山卫生系统转化科学中心
- 批准号:
10702195 - 财政年份:2023
- 资助金额:
$ 43.81万 - 项目类别:
Genetic and biophysical analysis of morphogen gradient formation
形态素梯度形成的遗传和生物物理分析
- 批准号:
10723239 - 财政年份:2023
- 资助金额:
$ 43.81万 - 项目类别:
Somatic control of germline differentiation in spermatogenesis.
精子发生中种系分化的体细胞控制。
- 批准号:
10741641 - 财政年份:2023
- 资助金额:
$ 43.81万 - 项目类别:
Diagnosing the Unknown for Care and Advancing Science (DUCAS)
诊断未知的护理和推进科学 (DUCAS)
- 批准号:
10682163 - 财政年份:2023
- 资助金额:
$ 43.81万 - 项目类别: